Search clinical trials for: Human immunodeficiency virus (HIV) infections

Total 72292 results

National Institute of Allergy and Infectious Diseases...

Completed

Promoting Adherence to Anti-HIV Drug Regimens

HIV Infections

United States
Gilead Sciences
Bristol-Myers Squibb

Completed

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

HIV Infections

United States, Puerto Rico
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services; Canadian...

Completed

Point of Care Tests for Syphilis and HIV (PoSH)

Syphilis

Canada
Northern Arizona University
National Institute on Minority Health and Health Disparities (NIMHD); Purdue... and other collaborators

Recruiting

e-HERO: Ending the HIV Epidemic in Rural Oklahoma (e-HERO)

Human Immunodeficiency Virus (HIV)

United States
Belgian Research on AIDS and HIV Consortium

Not yet recruiting

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

Human Immunodeficiency Virus
University Hospital, Geneva
Swiss HIV Cohort Study

Unknown

Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring (TDM)

HIV Infections | Human Immunodeficiency Virus

Switzerland
The HIV Netherlands Australia Thailand Research...
Roche for trial and Saquinavir,and Abbott for Kaletra

Completed

A PK and Salvage Study for Children With HIV-infection

HIV Infections

Thailand
Janssen Sciences Ireland UC

Completed

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

HIV-1

United States, South Africa, Ukraine, Kenya, Thailand, India, Romania, Uganda
Hunter College of City University of New York
National Institute on Drug Abuse (NIDA); University of Michigan

Enrolling by invitation

Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection (4Us Part B)

HIV Infections

United States
Gilead Sciences

Completed

Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters

HIV-1-infection

United States, Dominican Republic, Thailand
Merck Sharp & Dohme LLC

Completed

Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)

HIV-1 Infection

United States, Italy, Russian Federation, South Africa, Thailand
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)

HIV-1 Infection

United States, Argentina, Canada, Chile, Colombia, France, Germany, Israel, Italy, Japan, South Africa, Spain, Taiwan
The HIV Netherlands Australia Thailand Research...
Bristol-Myers Squibb

Completed

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

HIV Infections

Thailand
University of Chile
ViiV Healthcare

Unknown

Proviral DNA as a Target for HIV-1 Resistance Analysis (HIV)

HIV Infections | HIV/AIDS | HIV Seropositivity | Viral Infection

Chile
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

HIV Infections

Australia
Fundación Pública Andaluza Progreso y Salud
Gilead Sciences

Completed

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." (hEPAtic)

Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

Spain
Instituto Mexicano del Seguro Social
Hospital Civil de Guadalajara

Completed

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

Human Immunodeficiency Virus
Johns Hopkins Bloomberg School of Public Health
University of California, San Francisco; University of Toronto; National Institute... and other collaborators

Completed

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

HIV-1 Virologic Response

South Africa
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

HIV Infections

United States
Kirby Institute

Not yet recruiting

Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART) (OPTIMAR)

HIV Infections | Weight Gain
Anna Griffiths, MRC
Medical Research Council; Wellcome Trust; Department for International Development... and other collaborators

Completed

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy (REALITY)

Human Immunodeficiency Virus

Malawi, Zimbabwe, Kenya, Uganda
Merck Sharp & Dohme LLC

Completed

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138) (RACING)

HIV Infections
Changi General Hospital
National University Hospital, Singapore; Merck Sharp & Dohme LLC

Completed

Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers

Human Immunodeficiency Virus

Singapore
ANRS, Emerging Infectious Diseases

Completed

Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity ("ImmunoCo27")

HIV Infection
University of California, San Francisco
National Institute on Minority Health and Health Disparities (NIMHD); Florida...

Completed

The OPENS Trial: Offering Women PrEP (Aim 1)

Sexually Transmitted Diseases | Human Immunodeficiency Virus Transmission

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir

HIV Infections

United States
The HIV Netherlands Australia Thailand Research...
Ministry of Education, Thailand

Completed

Dose Reduction of Lopinavir in Children

HIV Infections

Thailand
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Medical Marijuana Use in HIV+ Patients: Probability Survey (MMS)

HIV Positive

United States
Gilead Sciences

Recruiting

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

HIV-1 Infection

United States, Thailand, Uganda, South Africa
Merck Sharp & Dohme LLC

Completed

Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)

HIV-1 Infection

United States, Australia, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Republic of, Peru, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
Merck Sharp & Dohme LLC

Active, not recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

HIV-1 Infection

United States, Australia, Chile, Israel, Japan, United Kingdom
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) (DRIVE-SHIFT)

HIV-1 Infection
University of Connecticut
Mercer University

Completed

Comparative Effectiveness of Brief HIV Care Counseling (SWIMS2)

HIV/AIDS

United States
University of Pennsylvania
Bill and Melinda Gates Foundation; Wits Reproductive Health and HIV Institute

Completed

Incentives to Promote Sustained Linkage to HIV Care

HIV/AIDS | Human Immunodeficiency Virus

South Africa
VaxGen

Completed

Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand

HIV Infections | HIV Seronegativity

Thailand
Westat
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...

Completed

Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP)

HIV | Pregnant Women | Zika Virus

United States, Puerto Rico, Brazil
The HIV Netherlands Australia Thailand Research...
Ministry of Education, Thailand

Completed

Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

HIV Infections | HIV Infection

Thailand
State University of Maringá

Completed

Resistance Training in People Living With HIV/AIDS

HIV/AIDS

Brazil
Emory University

Completed

Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV) (BLIR-HIV)

HIV Infection | Osteoporosis | Bone Loss | Osteopenia

United States
Bavarian Nordic

Completed

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

HIV Infections

Germany
Centro Universitario de Ciencias de la Salud, Mexico

Unknown

Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients

HIV Infections | Hepacivirus

Mexico
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission

HIV Infections

South Africa
Centers for Disease Control and Prevention

Completed

Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS

HIV Infections
Ottawa Hospital Research Institute
Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network

Completed

Micronutrients and Antioxidants in HIV Infection (MAINTAIN)

HIV Infection

Canada
National Taiwan University Hospital

Completed

Spatial Epidemiology of HIV Infection

HIV Infections | Acquired Immunodeficiency Syndrome

Taiwan
Merck Sharp & Dohme LLC

Active, not recruiting

Dose Ranging, Switch Study of Islatravir (ISL) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

HIV-1 Infection

United States, France, Switzerland
Merck Sharp & Dohme LLC

Active, not recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

HIV-1 Infection

United States, Australia, Canada, Colombia, Japan, South Africa, Switzerland, United Kingdom
Merck Sharp & Dohme LLC

Completed

Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)

HIV-1 Infection

United States, Israel, South Africa

Search clinical trials for: Human immunodeficiency virus (HIV) infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations